Lowering Triglycerides to Modify Cardiovascular Risk: Will Icosapent Deliver?

Vascular Health and Risk Management
doi 10.2147/vhrm.s40134
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Icosapent Ethyl Reduces Atherogenic Markers in High-Risk Statin-Treated Patients With Stage 3 Chronic Kidney Disease and High Triglycerides

Postgraduate Medicine
Medicine
2019English

Points: "Who Will Deliver Your Baby?"

BMJ
1981English

Who Will Deliver Innovations in Wound Care to the Patient?

International Journal of Lower Extremity Wounds
MedicineSurgery
2017English

Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients

Mayo Clinic Proceedings
Medicine
2019English

Blood Pressure Lowering for Cardiovascular Disease

The Lancet
Medicine
2016English

Nonfasting Triglycerides and Risk of Cardiovascular Death in Men and Women From the Norwegian Counties Study

European Journal of Epidemiology
Epidemiology
2010English

HTA for Pharmaceuticals in Europe: Will the Mountain Deliver a Mouse?

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2019English

Poststernotomy Mediastinitis; Early Risk Factors Identified but Hard to Modify

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy